Core Viewpoint - The Chemours Company has successfully completed a private offering of $700,000,000 in senior unsecured notes with a 7.875% interest rate, maturing in 2034, to fund the redemption of existing senior notes and manage its debt obligations [1]. Group 1: Offering Details - The offering consists of $700,000,000 aggregate principal amount of 7.875% senior unsecured notes due 2034, which are exempt from the registration requirements of the Securities Act of 1933 [1]. - The notes are Chemours' senior unsecured obligations and are guaranteed by one of its subsidiaries [1]. - The offering was made only to qualified institutional buyers and non-U.S. persons under specific regulations [1]. Group 2: Use of Proceeds - The net proceeds from the offering, along with cash on hand, will be used to redeem $188,000,000 of 5.750% senior notes due 2028 at an aggregate redemption price of approximately $189,800,000 [1]. - The remaining proceeds are expected to fund the redemption of outstanding 5.375% senior notes due 2027, estimated at an aggregate redemption price of approximately $500,300,000 [1]. Group 3: Company Overview - The Chemours Company is a global leader in industrial and specialty chemicals, serving markets such as coatings, plastics, refrigeration, and advanced electronics [1]. - The company operates through three main business segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials [1]. - Chemours is headquartered in Wilmington, Delaware, employs approximately 5,700 people, and serves around 2,400 customers in about 110 countries [1].

Core Insights - Chemours Company has priced a private offering of $700 million in senior notes with an interest rate of 7.875%, increasing from the initially announced $600 million [1][6] - The notes are set to mature on March 15, 2034, with semi-annual interest payments, and will be guaranteed by certain subsidiaries of Chemours [2][6] - The proceeds from this offering will be used to redeem existing 5.375% senior notes due in 2027 and partially redeem 5.750% senior notes due in 2028, thereby improving the company's debt profile [2][6] Financial Performance - Chemours stock has increased by 31.6% over the past year, contrasting with a 9.8% decline in the industry [3] - The company currently holds a Zacks Rank of 4 (Sell), indicating a less favorable outlook compared to other stocks in the Basic Materials sector [4] - Comparatively, other companies in the sector such as Albemarle Corporation and Compañía de Minas Buenaventura S.A.A. have higher Zacks Ranks of 1 (Strong Buy) and 2 (Buy) respectively, with significant year-over-year earnings growth projections [4][7][8][9]

Core Thesis - The Chemours Company presents a contrarian investment opportunity characterized by cyclical recovery, structural growth, and attractive valuation despite ongoing PFAS litigation concerns [2][5]. Valuation and Market Sentiment - As of February 24th, Chemours' share price was $18.41, with trailing and forward P/E ratios of 61.78 and 7.20 respectively [1]. - The company's valuation stands at 0.31x sales, significantly below the industry average of 1.08x, reflecting market pessimism and discounting much of the legal risk associated with PFAS litigation [2][3]. Business Strengths and Growth Potential - Chemours' core operations, particularly the Opteon refrigerants business and Advanced Performance Materials segment, are well-positioned for growth driven by increasing demand from data centers and the semiconductor industry [3]. - These end markets are expected to provide durable tailwinds that could lead to substantial revenue and margin expansion in the coming years [3]. Litigation and Future Outlook - The company is navigating through the PFAS litigation cycle, with 2026 anticipated to be a pivotal year as settlement visibility improves, potentially alleviating a major uncertainty that has impacted the stock [4]. - For investors willing to accept legal risks, Chemours offers access to high-quality businesses at deeply discounted valuations, creating a compelling risk/reward scenario [4][5]. Investment Considerations - The combination of an undervalued stock, structurally growing end markets, and the potential resolution of PFAS liabilities presents an attractive entry point for long-term investors seeking both value and growth upside [5]. - Positive developments regarding litigation settlements or operational execution could lead to a significant rerating of Chemours' shares [5].

Core Viewpoint - The Chemours Company has announced the pricing and upsizing of its private offering of $700 million in senior notes, reflecting a strategic move to refinance existing debt and optimize its capital structure [1]. Group 1: Offering Details - The offering size was increased from the initially announced $600 million to $700 million [1]. - The new senior notes will have an interest rate of 7.875% per annum and are set to mature on March 15, 2034 [1]. - Interest payments on the notes will be made semi-annually, starting from September 15, 2026 [1]. Group 2: Use of Proceeds - The net proceeds from the offering will be utilized to redeem outstanding 5.375% senior notes due in 2027 and partially redeem 5.750% senior notes due in 2028 [1]. Group 3: Company Overview - Chemours is a global leader in industrial and specialty chemicals, serving various markets including coatings, plastics, and advanced electronics [1]. - The company operates through three main business segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials [1]. - Chemours is headquartered in Wilmington, Delaware, employs approximately 5,700 people, and serves around 2,400 customers across 110 countries [1].

Core Insights - Pomerantz LLP is investigating claims on behalf of investors of The Chemours Company regarding potential securities fraud or unlawful business practices [1] - Chemours reported a significant decline in its stock price following the announcement of its fourth quarter and full year 2025 financial results, which included a one-time inventory charge affecting EBITDA [1] Financial Performance - Chemours disclosed that its 2025 EBITDA was negatively impacted by a one-time inventory charge in the Advanced Performance Materials segment [1] - The company cited "short-term cyclical end market headwinds" as a contributing factor to the financial results [1] - Following the financial report, Chemours's stock price fell by $3.37 per share, or 16.51%, closing at $17.04 per share on February 20, 2026 [1]

Group 1 - The Chemours Company announced a private offering of $600,000,000 in senior notes due 2034, which will be senior unsecured obligations guaranteed by a subsidiary [1] - The proceeds from the offering will be used to redeem outstanding 5.375% senior notes due 2027 and a portion of 5.750% senior notes due 2028 [1] - The offering is targeted at qualified institutional buyers under Rule 144A and non-U.S. persons under Regulation S of the Securities Act [1] Group 2 - Chemours is a global leader in industrial and specialty chemicals, serving markets such as coatings, plastics, refrigeration, and advanced electronics [1] - The company operates through three business segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials [1] - Chemours has approximately 5,700 employees and 28 manufacturing sites, serving around 2,400 customers in approximately 110 countries [1]

Core Insights - Chemours and 2CRSi have entered into a Joint Development Agreement (JDA) to enhance the deployment of two-phase liquid cooling technologies for high-density servers and IT equipment, following the successful qualification of Chemours' Opteon™ fluid in 2CRSi servers [1] - The partnership aims to combine Chemours' thermal management expertise with 2CRSi's server design capabilities to address the growing demands of AI and advanced IT workloads while significantly reducing energy and water consumption [1] - Chemours' Opteon™ solutions can achieve up to a 90% reduction in data center cooling energy compared to traditional air cooling, with a power usage effectiveness (PUE) approaching 1, and promote fluid recovery and reuse [1] Company Overview - Chemours is a global leader in industrial and specialty chemicals, providing solutions across various markets, including coatings, plastics, and advanced electronics, with a workforce of approximately 5,700 employees and operations in around 110 countries [1] - 2CRSi specializes in high-performance computer servers and innovative solutions for AI and high-performance computing, emphasizing energy efficiency and sustainability in its operations [1] Technological Advancements - The collaboration will focus on developing advanced two-phase cooling technologies, including direct-to-chip and immersion systems, to support high-density IT infrastructure [1] - 2CRSi has successfully commercialized ultra-high-density servers, such as the Atlas 1.8GG 2PIC model, which houses 8 NVIDIA H200 GPUs in a compact 1U format, enabled by two-phase cooling technology [1] Market Implications - The partnership reflects a shared vision to meet the increasing energy demands of AI and GPU-accelerated computing, paving the way for energy-efficient edge data centers capable of supporting low-latency applications like autonomous vehicles and 5G/6G networks [1]

Core Insights - Gabelli Funds will host its 17th Annual Specialty Chemicals Symposium on March 19, 2026, in Midtown Manhattan, focusing on industry dynamics, current trends, and business fundamentals in the specialty chemicals sector [1][2]. Group 1: Event Details - The symposium will feature discussions with leading companies and organizations within the specialty chemicals ecosystem [1]. - Attendees will have the opportunity for one-on-one meetings with management teams, and a webcast option will be available for those unable to attend in person [2]. Group 2: Presenting Companies - The symposium will include presentations from notable companies such as Arq, Inc., Ashland Global, BASF SE, and The Chemours Company, among others [3]. - A total of 12 companies are listed as presenters, with some indicating virtual attendance options [3][4].

Thermal & Specialized Solutions - The Thermal & Specialized Solutions segment is a leading global provider of refrigerants and thermal management solutions, with a focus on sustainable technologies like Opteon™, which has a near-zero ozone-depletion footprint [34]. - In 2023, the company announced the initial commercialization of Opteon™ 2P50, aimed at meeting the growing demand for cooling capacities driven by advancements in AI and data transmission [35]. - The company plans to expand its Opteon™ YF capacity at the Corpus Christi facility by approximately 40% to meet customer needs for lower GWP refrigerants, with mechanical completion expected in Q4 2024 [35]. Titanium Technologies - The Titanium Technologies segment has a nameplate capacity of approximately 1.1 million metric tons per year for TiO2 pigment, with production facilities located in the U.S. and Mexico [44]. - The Titanium Technologies Transformation Plan aims to streamline operations and achieve cost savings of $50 million in 2023 and $140 million in 2024, with ongoing savings captured under the Operational Excellence strategy [50]. - The company sold land from its Kuan Yin, Taiwan manufacturing site for approximately $360 million, intending to use proceeds to reduce debt obligations [51]. - The worldwide demand for TiO2 pigment in 2025 was estimated at approximately 7.3 million metric tons, with nameplate capacity at around 10 million metric tons [53]. - The company has diversified sourcing strategies for raw materials, including titanium-bearing ores, to ensure competitive supply chains and mitigate risks associated with single suppliers [56]. - The Titanium Technologies segment's transformation includes shutting down the Kuan Yin facility, completed in Q4 2023, to enhance manufacturing efficiency [50]. - The company serves approximately 800 customers globally, with no single customer representing more than 10% of the segment's net sales in 2025 [42]. - Chlorine is a key raw material, with a chlor-alkali facility planned for 2024 at the TiO2 plant in DeLisle, Mississippi, to enhance supply and reduce transportation costs [58]. - Energy costs represent approximately 10% of the production cost for TiO2 pigment, with access to low-cost natural gas in U.S. and Mexico facilities [60]. - In 2025, the top 10 customers in the Titanium Technologies segment accounted for over 44% of net sales, with one customer representing over 20% [65]. - The demand for TiO2 pigment is seasonal, typically peaking in the second and third quarters due to weather and holiday influences [66]. Advanced Performance Materials - The Advanced Performance Materials segment serves approximately 900 customers globally, with no single customer exceeding 10% of net sales in 2025 [78]. - The segment is positioned for growth driven by clean energy and advanced electronics, with a focus on technology development [71]. - The Advanced Performance Materials segment's products are critical for emerging technologies, including hydrogen production and fuel cells [69]. Sustainability and Environmental Goals - Sustainability is integral to Chemours' growth strategy, with a focus on minimizing environmental impact and aligning with climate action goals [90]. - Chemours aims for a 60% absolute reduction in Scope 1 and Scope 2 GHG emissions by 2030, alongside a 25% reduction in Scope 3 emissions intensity per ton of product [94]. - The Opteon™ portfolio has successfully avoided over 350 million tons of global CO2-equivalent emissions, achieving the 2025 goal ahead of schedule [93]. - Chemours has committed to achieving net zero greenhouse gas emissions from operations by 2050, with near-term science-based targets approved by the SBTi in May 2024 [91]. - The company is focused on developing low global warming potential refrigerants and enhancing product sustainability through its Ti-Pure™ Sustainability product series [97]. - Chemours is actively managing compliance costs related to environmental regulations, which are expected to remain significant due to evolving legislation [99]. Workforce and Talent Development - The company employs approximately 5,700 full-time employees globally, with 79% located in the Americas [102]. - Chemours' voluntary attrition rate for the year ended December 31, 2025, was approximately 7%, indicating strong employee retention [111]. - The company is implementing a structured talent development system to enhance skills and leadership capabilities across its workforce [107]. Financial and Risk Management - As of December 31, 2025, the company had 9 foreign currency forward contracts with a gross notional U.S. dollar equivalent of $170 million, resulting in a net loss of less than $1 million for the year [526]. - The company had 170 foreign currency forward contracts under a cash flow hedge program with a notional U.S. dollar equivalent of $214 million as of December 31, 2025, recognizing a pre-tax loss of $17 million for the year [527]. - The company recognized a pre-tax loss of $56 million on its net investment hedge for the year ended December 31, 2025, related to euro-denominated debt [528]. - A cross-currency swap was entered into to convert $600 million of senior unsecured notes into €567 million, with a fair value of $59 million as of December 31, 2025, resulting in a pre-tax loss of $64 million [529]. - The company had two interest rate swaps with a notional U.S. dollar equivalent of $300 million as of December 31, 2025, recognizing a pre-tax loss of less than $1 million for the year [531]. - One individual customer represented approximately 7% of total outstanding accounts and notes receivable as of December 31, 2025, indicating a diversified customer base [532]. - The company maintains strong credit controls and may require financial guarantees from customers in certain circumstances [533]. - The company did not have any commodity derivative financial instruments in place as of December 31, 2025, to mitigate commodity price fluctuations [534].

Core Viewpoint - The Chemours Company (CC) shares have increased by approximately 9% over the past year, but this figure conceals significant volatility, with share prices fluctuating between $9 and $22. Following a strong performance, the stock experienced a 17% decline last week due to weaker Q4 earnings [1]. Company Performance - The Chemours Company's stock has shown a notable increase of about 9% year-over-year, indicating some level of investor confidence despite the volatility [1]. - The stock has traded within a wide range, from $9 to $22, highlighting the instability in its market performance [1]. - A significant drop of 17% occurred last week, attributed to disappointing Q4 earnings results [1].